Issue 54, 2021

Stimuli-activated molecular photothermal agents for cancer therapy

Abstract

Taking advantage of activatable and imaging-guided properties, stimuli-activated molecular photothermal agents (MPTAs) have drawn great attention in photothermal therapy (PTT) over the past decades. In this review, the recent progress in the study of stimuli-activated MPTAs is summarized from different stimuli, including pH, bioactive small molecules, and enzymes. The features and challenges of stimuli-activated MPTAs are also discussed. This review aims to motivate readers to design and synthesise more efficient MPTAs.

Graphical abstract: Stimuli-activated molecular photothermal agents for cancer therapy

Article information

Article type
Feature Article
Submitted
21 Apr 2021
Accepted
24 May 2021
First published
25 May 2021

Chem. Commun., 2021,57, 6584-6595

Stimuli-activated molecular photothermal agents for cancer therapy

K. Wang, S. Xue, X. Liu, W. Pan, N. Li and B. Tang, Chem. Commun., 2021, 57, 6584 DOI: 10.1039/D1CC02116H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements